Skip to main content
Top
Published in: Diabetologia 9/2010

01-09-2010 | Article

Evidence of increased islet cell proliferation in patients with recent-onset type 1 diabetes

Authors: A. Willcox, S. J. Richardson, A. J. Bone, A. K. Foulis, N. G. Morgan

Published in: Diabetologia | Issue 9/2010

Login to get access

Abstract

Aims/hypothesis

In adults, the rate of beta cell replication is normally very low, but recent evidence suggests that it may increase during insulitis. We therefore studied tissue from donors with recent-onset type 1 diabetes to establish whether islet cell proliferation is increased during the disease process.

Methods

Paraffin-embedded pancreatic sections from ten donors with recent-onset type 1 diabetes and a range of relevant controls were stained by immunohistochemical techniques with antibodies against the proliferation markers Ki67 and minichromosome maintenance protein-2 (MCM-2). A combination staining technique involving immunoperoxidase and immunofluorescence methods was developed to quantify the numbers of alpha and beta cells with Ki67-positive nuclei and to investigate the relationship between insulitis and islet cell proliferation.

Results

In non-diabetic control donors, only 1.1 ± 0.3% (mean ± SEM) of islets contained one or more Ki67+ islet cells, whereas this proportion was increased markedly in recent-onset type 1 diabetes (10.88 ± 2.5%; p < 0.005). An equivalent increase in Ki67+ staining occurred in alpha and beta cells and was correlated positively with the presence of insulitis. A significant increase in the labelling of islet cells from type 1 diabetic donors was also seen when MCM-2 staining was employed. Increased islet cell proliferation was not evident in three donors with longer duration type 1 diabetes or in ten type 2 diabetic donors.

Conclusions/interpretation

Alpha and beta cells undergo a marked increase in proliferation during the progression of type 1 diabetes in humans. The results imply that islet cell proliferation is re-initiated in response to the autoimmune attack associated with type 1 diabetes.
Appendix
Available only for authorised users
Literature
1.
go back to reference Foulis AK (1996) The pathology of the endocrine pancreas in type 1 (insulin-dependent) diabetes mellitus. APMIS 104:161–167CrossRefPubMed Foulis AK (1996) The pathology of the endocrine pancreas in type 1 (insulin-dependent) diabetes mellitus. APMIS 104:161–167CrossRefPubMed
2.
go back to reference Atkinson MA, Gianani R (2009) The pancreas in human type 1 diabetes: providing new answers to age-old questions. Curr Opin Endocrinol Diab Obes 16:279–285 Atkinson MA, Gianani R (2009) The pancreas in human type 1 diabetes: providing new answers to age-old questions. Curr Opin Endocrinol Diab Obes 16:279–285
3.
go back to reference Meier JJ, Butler AE, Saisho Y et al (2008) Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta-cell mass in humans. Diabetes 57:1584–1594CrossRefPubMed Meier JJ, Butler AE, Saisho Y et al (2008) Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta-cell mass in humans. Diabetes 57:1584–1594CrossRefPubMed
4.
go back to reference Cnop M, Hughes SJ, Igoillo-Esteve M et al (2009) The long lifespan and low turnover of human islet beta cells estimated by mathematical modelling of lipofuscin accumulation. Diabetologia 53:321–330CrossRefPubMed Cnop M, Hughes SJ, Igoillo-Esteve M et al (2009) The long lifespan and low turnover of human islet beta cells estimated by mathematical modelling of lipofuscin accumulation. Diabetologia 53:321–330CrossRefPubMed
5.
go back to reference Dhawan S, Georgia S, Bhushan A (2007) Formation and regeneration of the endocrine pancreas. Curr Opin Cell Biol 19:634–645CrossRefPubMed Dhawan S, Georgia S, Bhushan A (2007) Formation and regeneration of the endocrine pancreas. Curr Opin Cell Biol 19:634–645CrossRefPubMed
6.
go back to reference Sorenson RL, Brelje TC (1997) Adaptation of islets of Langerhans to pregnancy: beta-cell growth, enhanced insulin secretion and the role of lactogenic hormones. Horm Metab Res 29:301–307CrossRefPubMed Sorenson RL, Brelje TC (1997) Adaptation of islets of Langerhans to pregnancy: beta-cell growth, enhanced insulin secretion and the role of lactogenic hormones. Horm Metab Res 29:301–307CrossRefPubMed
7.
go back to reference Rieck S, Kaestner KH (2009) Expansion of beta-cell mass in response to pregnancy. Trends Endocrinol Metab: TEM 21:151–158CrossRefPubMed Rieck S, Kaestner KH (2009) Expansion of beta-cell mass in response to pregnancy. Trends Endocrinol Metab: TEM 21:151–158CrossRefPubMed
8.
go back to reference In't Veld P, Lievens D, de Grijse J et al (2007) Screening for insulitis in adult autoantibody-positive organ donors. Diabetes 56:2400–2404CrossRefPubMed In't Veld P, Lievens D, de Grijse J et al (2007) Screening for insulitis in adult autoantibody-positive organ donors. Diabetes 56:2400–2404CrossRefPubMed
9.
go back to reference Sreenan S, Pick AJ, Levisetti M, Baldwin AC, Pugh W, Polonsky KS (1999) Increased beta-cell proliferation and reduced mass before diabetes onset in the nonobese diabetic mouse. Diabetes 48:989–996CrossRefPubMed Sreenan S, Pick AJ, Levisetti M, Baldwin AC, Pugh W, Polonsky KS (1999) Increased beta-cell proliferation and reduced mass before diabetes onset in the nonobese diabetic mouse. Diabetes 48:989–996CrossRefPubMed
10.
go back to reference Sherry NA, Kushner JA, Glandt M, Kitamura T, Brillantes AM, Herold KC (2006) Effects of autoimmunity and immune therapy on beta-cell turnover in type 1 diabetes. Diabetes 55:3238–3245CrossRefPubMed Sherry NA, Kushner JA, Glandt M, Kitamura T, Brillantes AM, Herold KC (2006) Effects of autoimmunity and immune therapy on beta-cell turnover in type 1 diabetes. Diabetes 55:3238–3245CrossRefPubMed
11.
go back to reference Nir T, Melton DA, Dor Y (2007) Recovery from diabetes in mice by beta cell regeneration. J Clin Investig 117:2553–2561CrossRefPubMed Nir T, Melton DA, Dor Y (2007) Recovery from diabetes in mice by beta cell regeneration. J Clin Investig 117:2553–2561CrossRefPubMed
12.
go back to reference Butler AE, Galasso R, Meier JJ, Basu R, Rizza RA, Butler PC (2007) Modestly increased beta cell apoptosis but no increased beta cell replication in recent-onset type 1 diabetic patients who died of diabetic ketoacidosis. Diabetologia 50:2323–2331CrossRefPubMed Butler AE, Galasso R, Meier JJ, Basu R, Rizza RA, Butler PC (2007) Modestly increased beta cell apoptosis but no increased beta cell replication in recent-onset type 1 diabetic patients who died of diabetic ketoacidosis. Diabetologia 50:2323–2331CrossRefPubMed
13.
go back to reference Meier JJ, Bhushan A, Butler AE, Rizza RA, Butler PC (2005) Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration? Diabetologia 48:2221–2228CrossRefPubMed Meier JJ, Bhushan A, Butler AE, Rizza RA, Butler PC (2005) Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration? Diabetologia 48:2221–2228CrossRefPubMed
14.
go back to reference Willcox A, Richardson SJ, Bone AJ, Foulis AK, Morgan NG (2009) Analysis of islet inflammation in human type 1 diabetes. Clin Exp Immunol 155:173–181CrossRefPubMed Willcox A, Richardson SJ, Bone AJ, Foulis AK, Morgan NG (2009) Analysis of islet inflammation in human type 1 diabetes. Clin Exp Immunol 155:173–181CrossRefPubMed
15.
go back to reference Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133:1710–1715PubMed Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133:1710–1715PubMed
16.
go back to reference Todorov IT, Attaran A, Kearsey SE (1995) BM28, a human member of the MCM2-3-5 family, is displaced from chromatin during DNA replication. J Cell Biol 129:1433–1445CrossRefPubMed Todorov IT, Attaran A, Kearsey SE (1995) BM28, a human member of the MCM2-3-5 family, is displaced from chromatin during DNA replication. J Cell Biol 129:1433–1445CrossRefPubMed
17.
go back to reference Meier JJ, Lin JC, Butler AE, Galasso R, Martinez DS, Butler PC (2006) Direct evidence of attempted beta cell regeneration in an 89-year-old patient with recent-onset type 1 diabetes. Diabetologia 49:1838–1844CrossRefPubMed Meier JJ, Lin JC, Butler AE, Galasso R, Martinez DS, Butler PC (2006) Direct evidence of attempted beta cell regeneration in an 89-year-old patient with recent-onset type 1 diabetes. Diabetologia 49:1838–1844CrossRefPubMed
18.
go back to reference Bone AJ, Walker R, Dean BM, Baird JD, Cooke A (1987) Pre-diabetes in the spontaneously diabetic BB/E rat: pancreatic infiltration and islet cell proliferation. Acta Endocrinol 115:447–454PubMed Bone AJ, Walker R, Dean BM, Baird JD, Cooke A (1987) Pre-diabetes in the spontaneously diabetic BB/E rat: pancreatic infiltration and islet cell proliferation. Acta Endocrinol 115:447–454PubMed
19.
go back to reference Lampeter EF, Tubes M, Klemens C et al (1995) Insulitis and islet-cell antibody formation in rats with experimentally reduced beta-cell mass. Diabetologia 38:1397–1404CrossRefPubMed Lampeter EF, Tubes M, Klemens C et al (1995) Insulitis and islet-cell antibody formation in rats with experimentally reduced beta-cell mass. Diabetologia 38:1397–1404CrossRefPubMed
20.
go back to reference Campbell-Thompson M, Dixon LR, Wasserfall C et al (2009) Pancreatic adenocarcinoma patients with localised chronic severe pancreatitis show an increased number of single beta cells, without alterations in fractional insulin area. Diabetologia 52:262–270CrossRefPubMed Campbell-Thompson M, Dixon LR, Wasserfall C et al (2009) Pancreatic adenocarcinoma patients with localised chronic severe pancreatitis show an increased number of single beta cells, without alterations in fractional insulin area. Diabetologia 52:262–270CrossRefPubMed
21.
go back to reference Phillips JM, O'Reilly L, Bland C, Foulis AK, Cooke A (2007) Patients with chronic pancreatitis have islet progenitor cells in their ducts, but reversal of overt diabetes in NOD mice by anti-CD3 shows no evidence for islet regeneration. Diabetes 56:634–640CrossRefPubMed Phillips JM, O'Reilly L, Bland C, Foulis AK, Cooke A (2007) Patients with chronic pancreatitis have islet progenitor cells in their ducts, but reversal of overt diabetes in NOD mice by anti-CD3 shows no evidence for islet regeneration. Diabetes 56:634–640CrossRefPubMed
22.
go back to reference Maedler K, Schumann DM, Sauter N et al (2006) Low concentration of interleukin-1beta induces FLICE-inhibitory protein-mediated beta-cell proliferation in human pancreatic islets. Diabetes 55:2713–2722CrossRefPubMed Maedler K, Schumann DM, Sauter N et al (2006) Low concentration of interleukin-1beta induces FLICE-inhibitory protein-mediated beta-cell proliferation in human pancreatic islets. Diabetes 55:2713–2722CrossRefPubMed
23.
go back to reference Ehses JA, Perren A, Eppler E et al (2007) Increased number of islet-associated macrophages in type 2 diabetes. Diabetes 56:2356–2370CrossRefPubMed Ehses JA, Perren A, Eppler E et al (2007) Increased number of islet-associated macrophages in type 2 diabetes. Diabetes 56:2356–2370CrossRefPubMed
24.
go back to reference Richardson SJ, Willcox A, Bone AJ, Foulis AK, Morgan NG (2009) Islet-associated macrophages in type 2 diabetes. Diabetologia 52:1686–1688CrossRefPubMed Richardson SJ, Willcox A, Bone AJ, Foulis AK, Morgan NG (2009) Islet-associated macrophages in type 2 diabetes. Diabetologia 52:1686–1688CrossRefPubMed
Metadata
Title
Evidence of increased islet cell proliferation in patients with recent-onset type 1 diabetes
Authors
A. Willcox
S. J. Richardson
A. J. Bone
A. K. Foulis
N. G. Morgan
Publication date
01-09-2010
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 9/2010
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-010-1817-6

Other articles of this Issue 9/2010

Diabetologia 9/2010 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.